Navigation Links
Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference
Date:11/17/2010

HOUSTON, Nov. 17, 2010 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the 22nd Annual Piper Jaffray Health Care Conference in New York on Tuesday, November 30, 2010 at 1:30 PM ET.  The conference session and webcast will be audio only and no formal slides will be presented.  Piper Jaffray will host a webcast of the presentation live and by replay at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYBX&item_id=3494627.  The conference webcast replay will be available for 90 days following the conference.  The conference webcast can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast.  Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy®Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation.  The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.Contact InformationGreg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262Fax:  (281) 218-9332ir@cyberonics.com
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cyberonics Provides Update on Depression Post-Approval Study
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
3. Cyberonics Provides Update on Tax Position
4. Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
5. Cyberonics Announces Epilepsy Technology Agreements
6. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
7. Cyberonics to Participate in Upcoming September Investor Conferences
8. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... 2017 Did you know that PhRMA member companies invested ... combined spending on brand medicines, generics and the supply chain account ... for just half of this (7 percent)? Or that ... world,s venture capital investments in high-growth biopharmaceutical startups? ... The ...
(Date:7/17/2017)... 17, 2017  MedX Holdings, Inc., the manufacturer and ... and rehabilitation equipment, today announced the national roll out ... considered the gold standard for the treatment of low ... strengthening equipment. How ... physician or practice who prescribe the MedX Home Back ...
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
Breaking Medicine Technology:
(Date:7/25/2017)... Beach, Florida (PRWEB) , ... July 25, 2017 ... ... employee, Jennifer Haller, to the sales department joining as Regional Account Manager for ... relationships with contracted customers in the liquidation of their obsolete medical assets. , ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... and finance management services to communities across North Carolina, is launching a charity ... to raise community support for the ongoing fight against bladder cancer. , The ...
(Date:7/25/2017)... ... 25, 2017 , ... Dr. Donna Bergman, professor of education ... published an article in the medical science journal Physical Medicine and Rehabilitation titled ... and the research that helped produce it, were written and conducted in collaboration ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... as medical director. Dr. Negrette has more than a decade of experience in ... worked closely with individuals fighting addictions, eating disorders, psychotic and manic conditions, as ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... for its Product Innovation in the prestigious CEO World Awards®. The coveted annual ... new products and services, CEO case studies, corporate social responsibility, and milestones from ...
Breaking Medicine News(10 mins):